MENU
HLBBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

H. Lundbeck A/S (HLBBF) Ownership - Who owns H. Lundbeck A/S?

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

Profile

Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
5.86B
P/E Ratio
9.98
Total Cash
4.66B
Projected Growth
7.60
Total Debt
16.69B
Revenue
22B
Risk (Beta)
0.28
Dividend Yield
0.03
Total Cash/Share
4.70
Total Debt/Equity
N/A
Revenue/Share
3.72 USD as % of share price

Fundamentals

HLBBF
Capitalization
5.86B
P/E Ratio
9.98
Risk (Beta)
0.28
Dividend Yield
0.03
Total Cash
4.66B
Total Cash/Share
4.70
Total Debt
16.7B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
7.60
Revenue/Share (as % of the share price)
3.72%
Revenue
22B
ROE
N/A
Book Value
25B
P/B Ratio
1.44
Cash Flow
N/A
Earnings
3.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
996M
Current Ratio
1.52
Current Revenue Per Employee
978975.25
Dividends Per Share - Security
0.00
EBITDA
5.71B
Float
N/A
Float - Current
N/A
Gross Income Margin
80.67
Revenue To Assets
6.66
Shares Held By Institutions
2.28B
Shares Outstanding - Current
992M
Total Liabilities
32B
Total Volume MTD
N/A
Value
1
Gain YTD
-10.324
View a ticker or compare two or three
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com